HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$87.36
Day range
$84.00 - $91.79
Year range
$20.04 - $105.00
Market cap
575.91M USD
Avg Volume
138.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.09M | 159.89% |
Net income | -3.44M | -163.56% |
Net profit margin | — | — |
Earnings per share | -0.48 | 74.05% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 143.68M | 2,286.61% |
Total assets | 144.20M | 2,275.71% |
Total liabilities | 2.64M | 135.06% |
Total equity | 141.56M | — |
Shares outstanding | 6.68M | — |
Price to book | 4.11 | — |
Return on assets | -10.33% | — |
Return on capital | -10.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.44M | -163.56% |
Cash from operations | -2.09M | -94.74% |
Cash from investing | -2.13M | -315.68% |
Cash from financing | 92.39M | 558,897.68% |
Net change in cash | 88.18M | 88,410.54% |
Free cash flow | -389.54K | 47.38% |
About
Founded
2014
Headquarters
Website
Employees
16
